Panitumumab in Japanese Patients with Unresectable Colorectal Cancer: A Post-marketing Surveillance Study of 3085 Patients†

Panitumumab in Japanese Patients with Unresectable Colorectal Cancer: A Post-marketing Surveillance Study of 3085 Patients†

Bibliographic Details
Main Authors:	Boku, Narikazu, Sugihara, Kenichi, Kitagawa, Yuko, Hatake, Kiyohiko, Gemma, Akihiko, Yamazaki, Naoya, Muro, Kei, Hamaguchi, Tetsuya, Yoshino, Takayuki, Yana, Ikuo, Ueno, Hiroshi, Ohtsu, Atsushi
Format:	Online
Language:	English
Published:	Oxford University Press 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941645/

Similar Items

Randomized study of FOLFIRI plus either panitumumab or bevacizumab for wild‐type KRAS colorectal cancer‐WJOG 6210G
by: Shitara, Kohei, et al.
Published: (2016)

Clinical features and risk factors of panitumumab-induced interstitial lung disease: a postmarketing all-case surveillance study
by: Osawa, Masahiro, et al.
Published: (2015)

Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer
by: Hezel, A F, et al.
Published: (2014)

A phase I study of intravenous aflibercept with FOLFIRI in Japanese patients with previously treated metastatic colorectal cancer
by: Yoshino, Takayuki, et al.
Published: (2012)

Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancer
by: Doi, Toshihiko, et al.
Published: (2015)

Phase I dose-escalation study of the HSP90 inhibitor AUY922 in Japanese patients with advanced solid tumors
by: Doi, Toshihiko, et al.
Published: (2014)

Feasibility of Cisplatin/5-Fluorouracil and Panitumumab in Japanese Patients with Squamous Cell Carcinoma of the Head and Neck
by: Tahara, Makoto, et al.
Published: (2014)

HER2-positive gastric cancer
by: Boku, Narikazu
Published: (2013)

Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)
by: Tahara, Makoto, et al.
Published: (2015)

Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer
by: Boku, Narikazu, et al.
Published: (2013)

Immunogenicity of panitumumab in combination chemotherapy clinical trials
by: Weeraratne, Dohan, et al.
Published: (2011)

Long-Term Treatment of Metastatic Colorectal Cancer with Panitumumab
by: López-Gómez, Miriam, et al.
Published: (2012)

Treatment of metastatic colorectal cancer: focus on panitumumab
by: Tay, Rebecca Y, et al.
Published: (2015)

Detecting new microRNAs in human osteoarthritic chondrocytes identifies miR-3085 as a human, chondrocyte-selective, microRNA
by: Crowe, N., et al.
Published: (2016)

Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study
by: Sawaki, Akira, et al.
Published: (2011)

Risk Factors for Severe Adverse Effects and Treatment-related Deaths in Japanese Patients Treated with Irinotecan-based Chemotherapy: A Postmarketing Survey†
by: Shiozawa, Tomoo, et al.
Published: (2013)

Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumab
by: Kim, George P, et al.
Published: (2008)

Safety and Pharmacokinetics of Motesanib in Combination with Panitumumab and Gemcitabine-Cisplatin in Patients with Advanced Cancer
by: Burris, Howard, et al.
Published: (2011)

Panitumumab-Induced Acneiform Rash in a Patient with Metastatic Colon Adenocarcinoma
by: Martins-Filho, Paulo Ricardo Saquete, et al.
Published: (2013)

A Case of Panitumumab-Responsive Metastatic Rectal Cancer Initially Refractory to Cetuximab
by: Kasagi, Yuta, et al.
Published: (2013)

Use of panitumumab in the treatment of acinar cell carcinoma of the pancreas: A case report
by: MORALES, MANUEL, et al.
Published: (2013)

Panitumumab in Metastatic Colorectal Cancer: The Importance of Tumour RAS Status
by: Peeters, Marc, et al.
Published: (2015)

Phase 1 study of ganitumab (AMG 479), a fully human monoclonal antibody against the insulin-like growth factor receptor type I (IGF1R), in Japanese patients with advanced solid tumors
by: Murakami, Haruyasu, et al.
Published: (2012)

Efficacy of palliative radiotherapy for gastric bleeding in patients with unresectable advanced gastric cancer: a retrospective cohort study
by: Kondoh, Chihiro, et al.
Published: (2015)

Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer
by: Sasaki, Yasutsuna, et al.
Published: (2014)

Klebsiella pneumoniae primary liver abscess associated with ruxolitinib
by: Kusano, Yoshiharu, et al.
Published: (2016)

Epstein-Barr virus gastric ulcer associated with ruxolitinib
by: Kusano, Yoshiharu, et al.
Published: (2016)

Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours
by: Doi, T, et al.
Published: (2012)

Unresectable gastrointestinal stromal tumors
by: Menon, Prema, et al.
Published: (2011)

Adoptive immunotherapy with MUC1-mRNA transfected dendritic cells and cytotoxic lymphocytes plus gemcitabine for unresectable pancreatic cancer
by: Shindo, Yoshitaro, et al.
Published: (2014)

Risk Factors for Esophageal Fistula Associated With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Cancer: A Supplementary Analysis of JCOG0303
by: Tsushima, Takahiro, et al.
Published: (2016)

Platelets Promote Tumor Growth and Metastasis via Direct Interaction between Aggrus/Podoplanin and CLEC-2
by: Takagi, Satoshi, et al.
Published: (2013)

Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts
by: TSUKIHARA, HIROSHI, et al.
Published: (2015)

Sorafenib for the treatment of unresectable hepatocellular carcinoma
by: Furuse, Junji
Published: (2008)

A Case of Unresectable Rectal Necrosis
by: Nassif, Mohammed, et al.
Published: (2011)

Photodynamic Therapy in Unresectable Cholangiocarcinoma: Not for the Uncommitted
by: Talreja, Jayant P., et al.
Published: (2013)

Oesophageal stent in unresectable cancer in elderly
by: Lanteri, Raffaele, et al.
Published: (2009)

Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
by: Watanabe, Toshiaki, et al.
Published: (2015)

Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment
by: Bennett, L, et al.
Published: (2011)

Safety and efficacy of panitumumab therapy after metastatic colorectal cancer progression with cetuximab: Experience at a single Japanese institution
by: SONODA, HIROMICHI, et al.
Published: (2013)